It was previously demonstrated that ZEB2 could promote metastasis of gastric cancer and colorectal cancer, a modulated epithelial-mesenchymal transition of gastric cancer cells, and was associated with poor prognosis of colorectal cancer 55, 56. This evidence concerns the gene ZEB2 and gastric cancer.